Profile picture

Doctor Tushar Kotecha

Royal Free Hospital, London (United Kingdom of Great Britain & Northern Ireland)
Membership: ESC Professional Member
Follow
Logo ESC

Contributor content

Outcomes following catheter-directed therapy for intermediate-high risk acute pulmonary embolism
Presentation
Outcomes following catheter-directed therapy for intermediate-high risk acute pulmonary embolism
Read more
PERT role in the decision-making process
Presentation
PERT role in the decision-making process
Read more
Discussion
Presentation
Discussion
Read more
Timely decision making in normotensive shock patient
Presentation
Timely decision making in normotensive shock patient
Read more
Do the current guidelines define the right treatment for all acute pulmonary embolism patients at risk for cardiogenic shock?
Presentation
Do the current guidelines define the right treatment for all acute pulmonary embolism patients at risk for cardiogenic shock?
Read more
Myocardial perfusion mapping in cardiac amyloidosis- exploring the spectrum from infiltration to ischaemia
Presentation
Myocardial perfusion mapping in cardiac amyloidosis- exploring the spectrum from infiltration to ischaemia
Read more
Quantitative CMR perfusion mapping to detect microvascular dysfunction in patients without obstructive coronary disease
Presentation
Quantitative CMR perfusion mapping to detect microvascular dysfunction in patients without obstructive coronary disease
Read more
Redefining assessment of adenosine stress response using CMR perfusion mapping: An alternative to splenic switch off
Presentation
Redefining assessment of adenosine stress response using CMR perfusion mapping: An alternative to splenic switch off
Read more
Quantification of myocardial infarct size and microvascular obstruction using dark-blood late gadolinium enhancement
Presentation
Quantification of myocardial infarct size and microvascular obstruction using dark-blood late gadolinium enhancement
Read more
Follow up CMR to track treatment response in cardiac al amyloidosis
Presentation
Follow up CMR to track treatment response in cardiac al amyloidosis
Read more

ESC 365 is supported by

novartis Explore sponsored resources